Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mathematical modeling of plus-strand RNA virus replication to identify broad-spectrum antiviral treatment strategies.
Zitzmann C, Dächert C, Schmid B, van der Schaar H, van Hemert M, Perelson AS, van Kuppeveld FJM, Bartenschlager R, Binder M, Kaderali L. Zitzmann C, et al. Among authors: kaderali l. PLoS Comput Biol. 2023 Apr 4;19(4):e1010423. doi: 10.1371/journal.pcbi.1010423. eCollection 2023 Apr. PLoS Comput Biol. 2023. PMID: 37014904 Free PMC article.
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.
Schneider C, Oellerich T, Baldauf HM, Schwarz SM, Thomas D, Flick R, Bohnenberger H, Kaderali L, Stegmann L, Cremer A, Martin M, Lohmeyer J, Michaelis M, Hornung V, Schliemann C, Berdel WE, Hartmann W, Wardelmann E, Comoglio F, Hansmann ML, Yakunin AF, Geisslinger G, Ströbel P, Ferreirós N, Serve H, Keppler OT, Cinatl J Jr. Schneider C, et al. Among authors: kaderali l. Nat Med. 2017 Feb;23(2):250-255. doi: 10.1038/nm.4255. Epub 2016 Dec 19. Nat Med. 2017. PMID: 27991919
Corrigendum: SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.
Schneider C, Oellerich T, Baldauf HM, Schwarz SM, Thomas D, Flick R, Bohnenberger H, Kaderali L, Stegmann L, Cremer A, Martin M, Lohmeyer J, Michaelis M, Hornung V, Schliemann C, Berdel WE, Hartmann W, Wardelmann E, Comoglio F, Hansmann ML, Yakunin AF, Geisslinger G, Ströbel P, Ferreirós N, Serve H, Keppler OT, Cinatl J Jr. Schneider C, et al. Among authors: kaderali l. Nat Med. 2017 Jun 6;23(6):788. doi: 10.1038/nm0617-788a. Nat Med. 2017. PMID: 28586337 No abstract available.
Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting.
Osterman A, Baldauf HM, Eletreby M, Wettengel JM, Afridi SQ, Fuchs T, Holzmann E, Maier A, Döring J, Grzimek-Koschewa N, Muenchhoff M, Protzer U, Kaderali L, Keppler OT. Osterman A, et al. Among authors: kaderali l. Med Microbiol Immunol. 2021 Feb;210(1):65-72. doi: 10.1007/s00430-020-00698-8. Epub 2021 Jan 16. Med Microbiol Immunol. 2021. PMID: 33452927 Free PMC article.
Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern.
Osterman A, Iglhaut M, Lehner A, Späth P, Stern M, Autenrieth H, Muenchhoff M, Graf A, Krebs S, Blum H, Baiker A, Grzimek-Koschewa N, Protzer U, Kaderali L, Baldauf HM, Keppler OT. Osterman A, et al. Among authors: kaderali l. Med Microbiol Immunol. 2021 Dec;210(5-6):263-275. doi: 10.1007/s00430-021-00719-0. Epub 2021 Aug 20. Med Microbiol Immunol. 2021. PMID: 34415422 Free PMC article.
Impaired detection of omicron by SARS-CoV-2 rapid antigen tests.
Osterman A, Badell I, Basara E, Stern M, Kriesel F, Eletreby M, Öztan GN, Huber M, Autenrieth H, Knabe R, Späth PM, Muenchhoff M, Graf A, Krebs S, Blum H, Durner J, Czibere L, Dächert C, Kaderali L, Baldauf HM, Keppler OT. Osterman A, et al. Among authors: kaderali l. Med Microbiol Immunol. 2022 Jun;211(2-3):105-117. doi: 10.1007/s00430-022-00730-z. Epub 2022 Feb 20. Med Microbiol Immunol. 2022. PMID: 35187580 Free PMC article.
148 results